The report includes the revenue generated from the sales of vaccines used for the prevention of various animal diseases. Recent advancements and developments in the animal vaccines market have enhanced the efficiency of these drugs. Drivers, restraints, and opportunities are explained in detail to understand the market dynamics. Key strategies adopted by the potential market leaders to facilitate effective planning and decision-making are also discussed. The animal vaccines market is classified into product, animal type, and region. By product, it is categorized into attenuated, inactivated, subunit, toxoid, conjugate, recombinant, and DNA vaccines. By animal type, it is divided into companion animal, livestock animal and aquaculture. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW 

CHAPTER 4: ANIMAL VACCINES MARKET, BY TYPE

CHAPTER 5: ANIMAL VACCINES MARKET, BY ANIMAL TYPE

CHAPTER 6: ANIMAL VACCINES MARKET, BY REGION

CHAPTER 7: COMPANY PROFILES